BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33599548)

  • 1. Association of illness perception with chemotherapy-induced nausea and vomiting: a Turkish Oncology Group (TOG) study.
    Kus T; Aktas G; Ozcelik M; Dirikoc M; Sakalar T; Oyman A; Tanriverdi O; Yavuzsen T; Unal S; Cinkir HY; Bahceci A; Alkan A; Turhal S; Abali H
    Future Oncol; 2021 May; 17(15):1933-1942. PubMed ID: 33599548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
    Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
    J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. population.
    Haiderali A; Menditto L; Good M; Teitelbaum A; Wegner J
    Support Care Cancer; 2011 Jun; 19(6):843-51. PubMed ID: 20532923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nausea and vomiting perspectives among children receiving moderate to highly emetogenic chemotherapy treatment.
    Rodgers C; Kollar D; Taylor O; Bryant R; Crockett K; Gregurich MA; Hockenberry M
    Cancer Nurs; 2012; 35(3):203-10. PubMed ID: 21915041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
    Hilarius DL; Kloeg PH; van der Wall E; van den Heuvel JJ; Gundy CM; Aaronson NK
    Support Care Cancer; 2012 Jan; 20(1):107-17. PubMed ID: 21258948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries.
    Hsieh RK; Chan A; Kim HK; Yu S; Kim JG; Lee MA; Dalén J; Jung H; Liu YP; Burke TA; Keefe DM
    Support Care Cancer; 2015 Jan; 23(1):263-72. PubMed ID: 25120009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey.
    Carnio S; Galetta D; Scotti V; Cortinovis DL; Antonuzzo A; Pisconti S; Rossi A; Martelli O; Cecere FL; Lunghi A; Del Conte A; Montagna ES; Topulli J; Pelizzoni D; Rapetti SG; Gianetta M; Pacchiana MV; Pegoraro V; Cataldo N; Bria E; Novello S
    Support Care Cancer; 2018 Jun; 26(6):1841-1849. PubMed ID: 29270827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer: A Preliminary Single-Center Study Investigating Medical and Psychosocial Risk Factors.
    Di Mattei VE; Carnelli L; Carrara L; Bernardi M; Crespi G; Rancoita PMV; Bergamini A; Petrone M; Ritella C; Rabaiotti E; Mangili G
    Cancer Nurs; 2016; 39(6):E52-E59. PubMed ID: 26895414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.
    Ihbe-Heffinger A; Ehlken B; Bernard R; Berger K; Peschel C; Eichler HG; Deuson R; Thödtmann J; Lordick F
    Ann Oncol; 2004 Mar; 15(3):526-36. PubMed ID: 14998860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice--a longitudinal analysis.
    Chan A; Kim HK; Hsieh RK; Yu S; de Lima Lopes G; Su WC; Baños A; Bhatia S; Burke TA; Keefe DM
    Support Care Cancer; 2015 Jan; 23(1):283-91. PubMed ID: 25112561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life.
    Fernández-Ortega P; Caloto MT; Chirveches E; Marquilles R; Francisco JS; Quesada A; Suárez C; Zorrilla I; Gómez J; Zabaleta P; Nocea G; Llombart-Cussac A
    Support Care Cancer; 2012 Dec; 20(12):3141-8. PubMed ID: 22460057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients.
    Morrow GR
    J Natl Cancer Inst; 1982 Apr; 68(4):585-8. PubMed ID: 6951074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.
    Liau CT; Chu NM; Liu HE; Deuson R; Lien J; Chen JS
    Support Care Cancer; 2005 May; 13(5):277-86. PubMed ID: 15770489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
    Kottschade L; Novotny P; Lyss A; Mazurczak M; Loprinzi C; Barton D
    Support Care Cancer; 2016 Jun; 24(6):2661-7. PubMed ID: 26768436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
    Baba Y; Baba H; Yamamoto S; Shimada H; Shibata T; Miyazaki T; Yoshikawa T; Nakajima Y; Tsuji Y; Shimokawa M; Kitagawa Y; Aiba K
    Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27001532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool.
    Matsuda Y; Okita K; Furuhata T; Kutomi G; Yamashita K; Sato Y; Takimoto R; Hirata K
    Support Care Cancer; 2015 Nov; 23(11):3331-9. PubMed ID: 26003425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting.
    Yap KY; Low XH; Chui WK; Chan A;
    J Clin Psychopharmacol; 2012 Apr; 32(2):207-17. PubMed ID: 22367655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor chemotherapy-induced nausea and vomiting control in children receiving intermediate or high dose methotrexate.
    Vol H; Flank J; Lavoratore SR; Nathan PC; Taylor T; Zelunka E; Maloney AM; Lee Dupuis L
    Support Care Cancer; 2016 Mar; 24(3):1365-71. PubMed ID: 26335406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticipatory Nausea, Risk Factors, and Its Impact on Chemotherapy-Induced Nausea and Vomiting: Results From the Pan European Emesis Registry Study.
    Molassiotis A; Lee PH; Burke TA; Dicato M; Gascon P; Roila F; Aapro M
    J Pain Symptom Manage; 2016 Jun; 51(6):987-93. PubMed ID: 26891606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective observational study on chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer by the CINV Study Group of Japan.
    Mizuno M; Hiura M; Kikkawa F; Numa F; Yaegashi N; Narahara H; Aoki D; Kimura E; Kato H; Shimokawa M; Sugiyama T; Kamura T
    Gynecol Oncol; 2016 Mar; 140(3):559-64. PubMed ID: 26748216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.